ginsenoside rh2 has been researched along with Breast Cancer in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, C; Hou, J; Kim, S; Yun, Y | 1 |
| Baek, M; Ji, HW; Jung, S; Kim, HW; Kim, SJ; Park, JE | 1 |
| Ham, J; Jeong, D; Ji, HW; Kim, H; Kim, HW; Kim, SJ; Park, S | 1 |
| Hou, J; Jeon, B; Kim, S; Xue, J; Yun, Y | 1 |
| Chen, Y; Huang, M; Li, T; Liu, C; Liu, M; Liu, Y; Mo, R; Qu, D; Shen, S; Wang, L | 1 |
| Ren, G; Shi, Z; Teng, C; Yao, Y | 1 |
| Cui, CH; Hou, JG; Jeon, BM; Kim, SC; Yun, YJ | 1 |
| Tang, JH; Wen, X; Yao, YF; Zhang, HD; Zhao, JH; Zhao, L | 1 |
| Choi, S; Kim, TW; Singh, SV | 1 |
| Tan, L; Tang, H; Xiao, X; Xie, Q; Xu, L; Yao, S; Zhang, Y; Zhou, B; Zhu, L | 1 |
| Hao, G; Lu, M; Sun, H; Wang, G; Wu, X; Zhang, J; Zhou, F | 1 |
| Choi, S; Choi, YH; Chung, H; Kim, DK; Kim, K; Kim, ND; Kim, SI; Oh, M | 1 |
12 other study(ies) available for ginsenoside rh2 and Breast Cancer
| Article | Year |
|---|---|
Ginsenoside Rh2 mitigates doxorubicin-induced cardiotoxicity by inhibiting apoptotic and inflammatory damage and weakening pathological remodelling in breast cancer-bearing mice.
Topics: Animals; Apoptosis; Breast Neoplasms; Cardiotoxicity; Doxorubicin; Endothelial Cells; Female; Ginsenosides; Humans; Mice; Mice, Nude; Myocytes, Cardiac; Necrosis; Oxidative Stress; RNA | 2022 |
Ginsenoside Rh2 Regulates the CFAP20DC-AS1/MicroRNA-3614-3p/BBX and TNFAIP3 Axis to Induce Apoptosis in Breast Cancer Cells.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Ginsenosides; Humans; MicroRNAs; RNA, Long Noncoding; RNA, Small Interfering; Tumor Necrosis Factor alpha-Induced Protein 3 | 2022 |
Ginsenoside Rh2 Suppresses Breast Cancer Cell Proliferation by Epigenetically Regulating the Long Noncoding RNA C3orf67-AS1.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Ginsenosides; Humans; MCF-7 Cells; Promoter Regions, Genetic; RNA, Long Noncoding | 2019 |
Doxorubicin-induced normal breast epithelial cellular aging and its related breast cancer growth through mitochondrial autophagy and oxidative stress mitigated by ginsenoside Rh2.
Topics: Autophagy; Breast Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Doxorubicin; Drugs, Chinese Herbal; Female; Ginsenosides; Humans; Mitochondria; Oxidative Stress | 2020 |
Oral Nanomedicine Based on Multicomponent Microemulsions for Drug-Resistant Breast Cancer Treatment.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Caco-2 Cells; Coix; Drug Liberation; Drug Resistance, Neoplasm; Drug Synergism; Emulsions; Etoposide; Excipients; Female; Ginsenosides; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice, Inbred ICR; Mice, Nude; Nanostructures; Plant Oils; Rats, Sprague-Dawley; Seeds; Xenograft Model Antitumor Assays | 2017 |
Antiproliferative Activity of Combined Biochanin A and Ginsenoside Rh₂ on MDA-MB-231 and MCF-7 Human Breast Cancer Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Genistein; Ginsenosides; Humans; MAP Kinase Kinase Kinase 5; MCF-7 Cells; p38 Mitogen-Activated Protein Kinases; Phosphorylation; TNF Receptor-Associated Factor 2; Tumor Suppressor Protein p53 | 2018 |
Ginsenoside Rh2 Ameliorates Doxorubicin-Induced Senescence Bystander Effect in Breast Carcinoma Cell MDA-MB-231 and Normal Epithelial Cell MCF-10A.
Topics: Apoptosis; Breast; Breast Neoplasms; Bystander Effect; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cellular Senescence; Doxorubicin; Epithelial Cells; Female; Ginsenosides; Humans; Interleukin-6; Neoplasm Invasiveness | 2019 |
Ginsenoside Rh2 differentially mediates microRNA expression to prevent chemoresistance of breast cancer.
Topics: Apoptosis; Blotting, Western; Breast Neoplasms; Cell Proliferation; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Female; Gene Expression Regulation, Neoplastic; Ginsenosides; Humans; MicroRNAs; Oligonucleotide Array Sequence Analysis; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured | 2015 |
Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of cyclin-dependent kinases.
Topics: Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Female; G1 Phase; Gene Knockdown Techniques; Ginsenosides; Humans; Protein Kinase Inhibitors | 2009 |
A dynamic study on reversal of multidrug resistance by ginsenoside Rh₂ in adriamycin-resistant human breast cancer MCF-7 cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Female; Ginsenosides; Humans; Microscopy, Fluorescence; Quartz Crystal Microbalance Techniques | 2012 |
Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2.
Topics: Active Transport, Cell Nucleus; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Female; Gene Expression Regulation, Neoplastic; Ginsenosides; Humans; I-kappa B Kinase; MCF-7 Cells; Mitogen-Activated Protein Kinases; NF-kappa B; Phosphorylation; Promoter Regions, Genetic; RNA Interference; Signal Transduction; Transcription Factor RelA; Transfection | 2012 |
Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carrier Proteins; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cell Division; Cyclin D; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; G1 Phase; Ginsenosides; Humans; Panax; Phosphorylation; Plants, Medicinal; Protein Serine-Threonine Kinases; Retinoblastoma Protein; Retinoblastoma-Binding Protein 1; Saponins; Transcription Factor DP1; Transcription Factors; Tumor Cells, Cultured | 1999 |